Hideyoshi Kaga

Effects of Synbiotic Supplementation on Chronic Inflammation and the Gut Microbiota in Obese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study

Akio Kanazawa, Masanori Aida, Y. Yoshida et al. · Nutrients · 2021 · 116 citations · Full text

Life Sciences, Microbiology, Nutrition +17

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Sarcopenic obesity is associated with cognitive impairment in community-dwelling older adults: The Bunkyo Health Study

Yuki Someya, Yoshifumi Tamura, Hideyoshi Kaga et al. · Clinical Nutrition · 2022 · 93 citations

Medicine, Geriatric Medicine, Nutrition +15

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Neuroimaging findings related to glymphatic system alterations in older adults with metabolic syndrome

Christina Andica, Koji Kamagata, Kaito Takabayashi et al. · Neurobiology of Disease · 2023 · 84 citations · Full text

Medicine, Neurobiology, Neuroscience +17